BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 19489863)

  • 1. Incontinentia pigmenti Stage 1 is not simply vesiculo-bullous but vesiculo-pustular.
    Çetinarslan T; Fölster-Holst R; Van Gysel D; Buchner M; Happle R
    Pediatr Dermatol; 2024; 41(1):182-183. PubMed ID: 38284782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system anomalies in 41 Chinese children incontinentia pigmenti.
    Yin L; Li Z; Zhan W; Kang Y; Tian Q; Li D; Zhang H
    BMC Neurosci; 2024 May; 25(1):25. PubMed ID: 38773385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.
    Figueiredo AC; Mata-Machado N; McCoyd M; Biller J
    Curr Neurol Neurosci Rep; 2016 Feb; 16(2):19. PubMed ID: 26759320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incontinentia pigmenti.
    Poziomczyk CS; Recuero JK; Bringhenti L; Maria FD; Campos CW; Travi GM; Freitas AM; Maahs MA; Zen PR; Fiegenbaum M; Almeida ST; Bonamigo RR; Bau AE
    An Bras Dermatol; 2014; 89(1):26-36. PubMed ID: 24626645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal dentition in a boy with incontinentia pigmenti: case report.
    Afshar H; Daneshpazhooh M; Kiani A; Aref P; Baniameri Z
    J Dent (Tehran); 2012; 9(3):267-70. PubMed ID: 23119137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incontinentia pigmenti.
    Cohen BA
    Neurol Clin; 1987 Aug; 5(3):361-77. PubMed ID: 3306331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incontinentia pigmenti: treatment of IP with topical tacrolimus.
    Jessup CJ; Morgan SC; Cohen LM; Viders DE
    J Drugs Dermatol; 2009 Oct; 8(10):944-6. PubMed ID: 19852125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative multicentre trial of halometasone/triclosan cream and diflucortolone valerate/chlorquinaldol cream in the treatment of acute dermatomycoses.
    Maeder E; Schindléry C; Macarol V; Schoenenberger PM
    J Int Med Res; 1983; 11 Suppl 1():48-52. PubMed ID: 6339293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neonate with linear rows of vesiculobullous lesions].
    Fernández MF; Samela PC; Buján MM; Merediz J; Pierini AM
    Arch Argent Pediatr; 2010 Feb; 108(1):e5-8. PubMed ID: 20204229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incontinentia Pigmenti with vesicular stage in utero.
    Osório F; Magina S; Nogueira A; Azevedo F
    Dermatol Online J; 2010 Oct; 16(10):13. PubMed ID: 21062607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incontinentia pigmenti.
    Motamedi MH; Lotfi A; Azizi T; Moshref M; Farhadi S
    Indian J Pathol Microbiol; 2010; 53(2):302-4. PubMed ID: 20551538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of topical corticosteroids in the vesiculobullous lesions of incontinentia pigmenti.
    Kaya TI; Tursen U; Ikizoglu G
    Clin Exp Dermatol; 2009 Dec; 34(8):e611-3. PubMed ID: 19489863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HPV-15 in painful subungual tumors of incontinentia pigmenti: successful topical therapy with retinoic acid.
    Donati P; Muscardin L; Amantea A; Paolini F; Venuti A
    Eur J Dermatol; 2009; 19(3):243-7. PubMed ID: 19213657
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.